Phase 2, open-label, international, non-comparative study of MEDI4736 in patients with locally advanced or metastatic, PD-L1 +, stage 3B-4 NSCLC who have received ≥2 prior systemic treatment regimens (ATLANTIC) Meeting Abstract
| Authors: | Gray, J. E.; Garassino, M. C.; Vansteenkiste, J. F.; Ballas, M.; Jayawardene, D.; Stockman, P. K.; Powderly, J. D.; Rizvi, N. |
| Abstract Title: | Phase 2, open-label, international, non-comparative study of MEDI4736 in patients with locally advanced or metastatic, PD-L1 +, stage 3B-4 NSCLC who have received ≥2 prior systemic treatment regimens (ATLANTIC) |
| Meeting Title: | 5th European Lung Cancer Conference (ELCC) |
| Journal Title: | Annals of Oncology |
| Volume: | 26 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Apr 15-18 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2015-04-01 |
| Start Page: | i43 |
| Language: | English |
| ACCESSION: | WOS:000354728700065 |
| DOI: | 10.1093/annonc/mdv050.43 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 139TiP -- Source: Wos |
